Spencer Laird, a young father and mechanic, first noticed blood in his stool at age 25. His doctor initially attributed it to hemorrhoids. Eighteen months later, at age 27, a colonoscopy revealed stage 4 colorectal cancer that had already spread to his lungs, according to a verified CBS News report from 2024.
After undergoing surgery and chemotherapy, Laird's cancer continued to progress. Facing limited options, he enrolled in a clinical trial at the University of Colorado Cancer Center. The trial combined the immunotherapy drug botensilimab with balstilimab, an investigational treatment for advanced, refractory solid tumors.
Medical experts note that while colorectal cancer rates are declining in older adults, they are rising among younger people. The reasons are not fully understood, but lifestyle and dietary factors are being studied. Early detection remains critical, as symptoms like rectal bleeding, changes in bowel habits, and abdominal pain can be mistaken for less serious conditions.
Laird's response to the clinical trial has been significant. Scans showed a dramatic reduction in his tumors, a result he described as "miraculous." His story highlights the importance of clinical research in developing new treatments for aggressive cancers and underscores the need for awareness of rising rates in younger populations.
